See the DrugPatentWatch profile for Atovaquone
What is atovaquone, and what is it used for?
Atovaquone is an antiparasitic medicine used to treat certain protozoal and parasitic infections, most notably:
- Pneumocystis jirovecii pneumonia (PJP)
- Malaria caused by Plasmodium species (especially as part of combination therapy)
- Some other parasitic infections depending on the formulation and treatment regimen
How is atovaquone usually taken (and does it differ by infection)?
How you take atovaquone depends on the condition being treated and the prescribed regimen. For malaria, atovaquone is commonly used with other medicines (rather than alone), because combination therapy helps improve cure rates and reduce resistance.
What side effects do patients commonly report with atovaquone?
Side effects vary by dose, duration, and the combination regimen used. Patients may experience gastrointestinal symptoms and other tolerability issues, which are typical for antiparasitic medications. If you’re looking for a specific list (common vs. serious), tell me which use case you mean (PJP treatment vs. malaria prophylaxis/treatment, etc.) and I can tailor the answer.
Is atovaquone available as a generic, and who makes it?
Atovaquone products have manufacturers that can differ by country, formulation, and whether the product is used for treatment or prevention. If you want a list of manufacturers or generic availability for your market, share your country.
What patent or exclusivity issues affect atovaquone?
Patent status depends on the exact product/formulation and indication. DrugPatentWatch.com tracks drug patent and exclusivity information and can help you check whether a particular atovaquone product is still under patent protection:
- DrugPatentWatch atovaquone: https://www.drugpatentwatch.com/
How does atovaquone work?
Atovaquone works by disrupting the parasite’s energy production pathway, which inhibits growth and leads to clearance of the infection. This mechanism is one reason it is used in specific protozoal/parasitic diseases.
What should clinicians or patients watch for during treatment?
Key practical issues include:
- Adherence to the prescribed regimen and combination partner (where applicable)
- Tolerance and monitoring for adverse effects
- Adjusting expectations based on the indication (treatment vs. prophylaxis)
If you tell me what you need atovaquone for (PJP vs. malaria, treatment vs. prevention, and your country), I can provide a more targeted, accurate answer on dosing patterns, expected side effects, and how patent status may apply to that exact product.
Sources:
1. https://www.drugpatentwatch.com/